Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.

Haroon E, Raison CL, Miller AH.

Neuropsychopharmacology. 2012 Jan;37(1):137-62. doi: 10.1038/npp.2011.205. Epub 2011 Sep 14. Review.

2.

Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats.

Wang Y, Yang F, Liu YF, Gao F, Jiang W.

Neurosci Lett. 2011 Jul 20;499(2):74-9. doi: 10.1016/j.neulet.2011.05.035. Epub 2011 May 23.

PMID:
21640159
3.

Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.

Felger JC, Alagbe O, Pace TW, Woolwine BJ, Hu F, Raison CL, Miller AH.

Brain Behav Immun. 2011 Aug;25(6):1094-8. doi: 10.1016/j.bbi.2011.02.015. Epub 2011 Feb 26.

4.

Subgenual anterior cingulate responses to peer rejection: a marker of adolescents' risk for depression.

Masten CL, Eisenberger NI, Borofsky LA, McNealy K, Pfeifer JH, Dapretto M.

Dev Psychopathol. 2011 Feb;23(1):283-92. doi: 10.1017/S0954579410000799.

5.

Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.

Sockalingam S, Links PS, Abbey SE.

J Viral Hepat. 2011 Mar;18(3):153-60. doi: 10.1111/j.1365-2893.2010.01393.x. Epub 2010 Nov 10. Review.

PMID:
21070503
6.

Association of high-sensitivity C-reactive protein with de novo major depression.

Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, Schneider HG, Leonard BE, Berk M.

Br J Psychiatry. 2010 Nov;197(5):372-7. doi: 10.1192/bjp.bp.109.076430.

7.

Immune suppression and immune activation in depression.

Blume J, Douglas SD, Evans DL.

Brain Behav Immun. 2011 Feb;25(2):221-9. doi: 10.1016/j.bbi.2010.10.008. Epub 2010 Oct 16. Review.

8.

Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward.

Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR.

Biol Psychiatry. 2010 Oct 15;68(8):748-54. doi: 10.1016/j.biopsych.2010.06.010. Epub 2010 Aug 16.

9.

Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?

Kenis G, Prickaerts J, van Os J, Koek GH, Robaeys G, Steinbusch HW, Wichers M.

Int J Neuropsychopharmacol. 2011 Mar;14(2):247-53. doi: 10.1017/S1461145710000830. Epub 2010 Jul 29.

PMID:
20667172
10.

The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature.

De Berardis D, Conti CM, Serroni N, Moschetta FS, Olivieri L, Carano A, Salerno RM, Cavuto M, Farina B, Alessandrini M, Janiri L, Pozzi G, Di Giannantonio M.

Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):417-22. Review.

PMID:
20646337
11.

Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR, Miller AH.

Biol Psychiatry. 2010 Nov 15;68(10):942-9. doi: 10.1016/j.biopsych.2010.04.019. Epub 2010 May 26.

12.

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.

Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE.

Am J Psychiatry. 2010 May;167(5):509-27. doi: 10.1176/appi.ajp.2010.09101452. Epub 2010 Mar 15. Review.

13.

Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood.

Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR.

Brain Behav Immun. 2010 May;24(4):558-63. doi: 10.1016/j.bbi.2009.12.009. Epub 2010 Jan 4.

14.

A meta-analysis of cytokines in major depression.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL.

Biol Psychiatry. 2010 Mar 1;67(5):446-57. doi: 10.1016/j.biopsych.2009.09.033. Epub 2009 Dec 16.

PMID:
20015486
15.

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.

Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH.

Mol Psychiatry. 2010 Apr;15(4):393-403. doi: 10.1038/mp.2009.116. Epub 2009 Nov 17.

16.

Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.

Schäfer A, Scheurlen M, Seufert J, Keicher C, Weissbrich B, Rieger P, Kraus MR.

J Hepatol. 2010 Jan;52(1):10-5. doi: 10.1016/j.jhep.2009.10.007. Epub 2009 Oct 21.

PMID:
19897271
17.

Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.

Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, Fallucca S, Alessi E, Letizia C, Jimenez A, Fallucca F, Pugliese G.

Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):608-17. doi: 10.1016/j.numecd.2009.04.015. Epub 2009 Aug 19.

PMID:
19695853
18.

Innate immune, neuroendocrine and behavioral responses to psychosocial stress do not predict subsequent compassion meditation practice time.

Pace TW, Negi LT, Sivilli TI, Issa MJ, Cole SP, Adame DD, Raison CL.

Psychoneuroendocrinology. 2010 Feb;35(2):310-5. doi: 10.1016/j.psyneuen.2009.06.008. Epub 2009 Jul 16.

19.

Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Prather AA, Rabinovitz M, Pollock BG, Lotrich FE.

Brain Behav Immun. 2009 Nov;23(8):1109-16. doi: 10.1016/j.bbi.2009.07.001. Epub 2009 Jul 15.

20.

Social stress enhances IL-1beta and TNF-alpha production by Porphyromonas gingivalis lipopolysaccharide-stimulated CD11b+ cells.

Bailey MT, Kinsey SG, Padgett DA, Sheridan JF, Leblebicioglu B.

Physiol Behav. 2009 Sep 7;98(3):351-8. doi: 10.1016/j.physbeh.2009.06.013. Epub 2009 Jun 26.

Supplemental Content

Support Center